English 
Español 
简体中文 
繁體中文 
한국어 
Português The latest market news & Insights
IBM Shares Fall as CEO Doubles Down on Quantum While Market Stays Skeptical
At New York Tech Week on Tuesday, IBM’s CEO made his strongest argument so far that quantum computing is real, ready for business, and closer than most people think. Even as Arvind Krishna called quantum the next step after CPUs and GPUs and promised a $10 billion investment over five years, IBM shares dropped along […]
Market Insights
Nestlé Shares Jump as Turnaround Plan Offsets Sales Drop
Nestlé shares rose nearly 6% Thursday after first-quarter sales beat forecasts. Sales were still down year over year. Still, investors saw early signs of progress under the new CEO, who is leading a major restructuring. This gain was notable amid Europe’s main stock index’s decline due to renewed Middle East tensions. Optimism about Nestlé, not […]
T-Mobile Shares Slip on Deutsche Telekom Merger Report
T-Mobile shares fell Tuesday after a report that its main shareholder, Deutsche Telekom, may fully merge with the U.S. carrier. Such a deal would need approval from both German and American regulators and politicians. Deutsche Telekom owns 53% of T-Mobile and is in early merger talks, the report said. The German government and bank KfW […]
Micron Stock Steady as SK Hynix $13B Plant Signals Supply
SK Hynix has begun construction of a nearly $13 billion advanced packaging facility in South Korea. This major investment highlights the memory chip sector’s growth, fueled by AI. However, if supply from new facilities grows faster than demand, Micron Technology investors could face risks from future market oversaturation, which could pressure prices and profits. The […]
TE Connectivity Shares Rise as AI and Industry Fuel Beat
TE Connectivity beat expectations in its fiscal second quarter, reporting higher earnings and revenue driven by strong demand for artificial intelligence and a solid recovery in industrial markets. These factors led to record order volumes. TE Connectivity reported $2.73 per share on $4.7 billion revenue, a 47% jump from last year’s $1.86 per share and […]
Nvidia Shares Rise Despite Google AI Chip Threat
NVIDIA shares rose Tuesday as investors shrugged off concerns over a possible new Google chip. NVIDIA’s stock has climbed about 15% over the past month and now approaches its October record high. This rebound signals that big investors continue to believe in Nvidia’s lead in the AI accelerator market, even as more competitors enter. Google […]
Avis Short Squeeze Sends Stock to Record Highs
A short squeeze, a situation in which investors betting against the stock are forced to buy shares as prices rise, occurred in Avis Budget Group shares, sending the stock to record highs. This was driven by an unusual ownership structure that leaves few shares available for trading. The stock has jumped over fivefold this month. […]
CrowdStrike Shares Upgraded as AI Threat Fears Turn Bullish
On Monday, KeyBanc raised its rating on CrowdStrike from Sector Weight to Overweight. The firm said some see Anthropic’s new advanced artificial intelligence model as a cybersecurity risk. However, KeyBanc believes this will actually boost demand for cybersecurity. KeyBanc analyst Eric Heath set a price target that suggests about 21% growth from Monday’s closing price. […]
Tesla Rises Ahead of Earnings as Robotaxi Outlook Looms
Tesla shares edged up Tuesday as investors awaited Wednesday’s earnings report, focusing more on management’s outlook for self-driving cars and robotics than near-term results. Analysts expect Tesla to report earnings of 36 cents per share on $22.3 billion in revenue. Some investors are focusing on Elon Musk’s updates about the robotaxi launch and the schedule […]
Eli Lilly Bets $7 Billion on Next-Generation Blood Cancer Therapy
Eli Lilly has agreed to acquire Boston-based Kelonia Therapeutics for up to $7 billion, marking a significant push by the Indianapolis pharmaceutical giant into the rapidly expanding oncology market. The transaction includes an upfront cash payment of $3.25 billion, with the remainder contingent on clinical, regulatory, and commercial milestones. Closing is anticipated in the second […]
Introduction to Stock Trading
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.